Avalyn Pharma Reports Statistically Significant Dose Response with Aerosolized Pirfenidone in an Idiopathic Pulmonary Fibrosis Trial
News published by Avalyn Pharma concerning AP01 (a formulation of pirfenidone optimized for delivery via inhalation), administered via an optimized eFlow® Technology nebulizer.